New obesity drug faces off against diet in metabolism showdown
NCT ID NCT07184086
Summary
This study is testing how a new combination drug called CagriSema affects the body's energy use compared to a weight-loss diet. Eighty adults with obesity will be randomly assigned to receive either the drug or follow a reduced-calorie diet for part of the study, then all will receive the drug. Researchers will measure how the body burns energy at rest and during sleep to understand the drug's effects on metabolism.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Advent Health-Res Inst
RECRUITINGOrlando, Florida, 32804, United States
-
Pennington Biomed Res Ctr
RECRUITINGBaton Rouge, Louisiana, 70808-4124, United States
Conditions
Explore the condition pages connected to this study.